The landscape of dementia prognosis has advanced significantly with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology many years prior to signs and symptoms arise. Though these technological advancements depict exceptional progress in being familiar with neurodegenerative https://muhammadh207clv6.nizarblog.com/profile